Bright Minds Biosciences Inc (DRUG) — Defensive Interval Ratio
Bright Minds Biosciences Inc (DRUG) has a Defensive Interval Ratio of 183 days as of June 2026. Defensive assets of $1.28 Million (cash $-, short-term investments $172.78K, receivables $1.10 Million) cover 183 days of daily cash needs of $6.98K/day. See DRUG current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Bright Minds Biosciences Inc Defensive Interval Ratio (2021–2025)
This chart shows how Bright Minds Biosciences Inc's Defensive Interval Ratio has evolved across 5 annual periods from 2021 to 2025. As of June 2026, the ratio stands at 183 days, meaning defensive assets of $1.28 Million can fund 183 days of operations without new revenue. Read Bright Minds Biosciences Inc debt and liabilities for a breakdown of total debt and financial obligations.
Annual Defensive Interval Ratio for Bright Minds Biosciences Inc (2021–2025)
The table below presents the year-by-year Defensive Interval Ratio for Bright Minds Biosciences Inc from 2021 to 2025, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see DRUG asset base.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 74 days | $475.00K | $6.40K/day | $- | $61.93K | ▲ +40 days |
| 2024 | 35 days | $50.22K | $1.45K/day | $- | $- | ▼ -125 days |
| 2023 | 160 days | $123.23K | $769.47/day | $- | $86.25K | ▲ +100 days |
| 2022 | 60 days | $242.03K | $4.03K/day | $- | $86.25K | ▼ -52 days |
| 2021 | 112 days | $196.40K | $1.75K/day | $- | $86.25K | — |